Chief Financial Officer · Krystal Biotech, Inc. (KRYS)

Antony Riley

A named executive officer of Krystal Biotech in every fiscal year CompBrief holds from FY2018 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$660,844

Salary $141,667Stock awards $0

FY2018: $278,161

1st of 4 named executive officers at Krystal Biotech by FY2019 total.

4 named officers on file for Krystal Biotech, FY2019

Antony Riley’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • KRYS’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Krystal Biotech’s whole pay program stands against its peers

  • Krystal Biotech’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on KRYS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 13, 2020 (DEF 14A).

Free

Get Antony Riley’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Antony Riley compensation by year

Krystal Biotech Summary Compensation Table · all 2 fiscal years held
In US dollars, as Krystal Biotech reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019
Salary$103,561$141,667
Bonus$0$0
Stock awards$0$0
Option awards$174,600$519,177
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$0$0
Total$278,161$660,844

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Krystal Biotech, Inc. DEF 14A filed April 13, 2020, accession 0001564590-20-016447, and prior-year filings.

How this page was built: the Krystal Biotech, Inc. filed document, accession 0001564590-20-016447. Every figure is read from that document and cited to the page and table it appears in. Filed April 13, 2020.

$278K
$661K
FY18
FY19
SalaryOption awards

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option18,750—$9.85
Option25,000—$25.02
Option25,000—$31.42

Per the Outstanding Equity Awards at Fiscal Year-End table in Krystal Biotech, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Krystal Biotech’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Antony Riley · this pageChief Financial Officer$660,844
Krish KrishnanChairman and Chief Executive Officer$365,725
Suma KrishnanChief Operating Officer$305,642
Pooja AgarwalSenior Vice President, Product Development$259,583

The full Krystal Biotech compensation record

free company brief

This page is one person within Krystal Biotech's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Krystal Biotech proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Krystal Biotech's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Antony Riley's compensation dossier · One-time report. No refunds.